MEDVi vs PeterMD: Which GLP-1 Provider Is Better?
A side-by-side comparison of MEDVi and PeterMD covering pricing, scores, medication types, insurance, and more to help you decide.
Higher Rated
MEDVi
#9 of 318.3/10
Compounded GLP-1 platform offering both oral and injectable options with flexible dosing and affordable pricing.
Visit MEDViPeterMD
#28 of 317.5/10
One of the most affordable compounded GLP-1 options on the market, ideal for budget-conscious patients.
Visit PeterMD| Feature | MEDVi | PeterMD |
|---|---|---|
| Our Score | 8.3/10 | 7.5/10 |
| Starting Price | $179/mo | $105/mo |
| Medication Type | Compounded | Compounded |
| Insurance Accepted | No | No |
| Best For | Users who want a low entry price with oral and injectable compounded options | Budget-conscious users looking for the lowest monthly GLP-1 cost |
| Ranking | #9 | #28 |
Pros & Cons Compared
MEDVi
Pros
- +One of the few compounded providers offering both oral tablets and injectable semaglutide
- +Micro-dosing options available — can start at sub-standard doses for patients concerned about side effects
- +Sleek onboarding experience with clear progress tracking through their patient portal
- +$179/mo is competitive for a platform with both oral and injectable compounded formulations
Cons
- −Compounded medications only — no path to brand-name Wegovy or Zepbound through their platform
- −No insurance accepted, and oral compounded semaglutide has less clinical data than injectable forms
PeterMD
Pros
- +Very affordable
- +Simple process
- +Low monthly cost
- +Easy onboarding
Cons
- −Compounded only
- −Less comprehensive support
Our Verdict
MEDVi edges out PeterMD with a score of 8.3/10 vs 7.5/10. If budget is your priority, PeterMD starts at $105/mo compared to MEDVi's $179/mo. Choose MEDVi if you want: users who want a low entry price with oral and injectable compounded options. Choose PeterMD if you want: budget-conscious users looking for the lowest monthly glp-1 cost.